Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AG-DESVENLAFAXINE DIN 02525615

Status: Marketed
Holder: ANGITA PHARMA INC.
Molecule: DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

Health Canada record

Active ingredient(s)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MG
Dosage formTablet (Extended-Release)
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCN06AX23 DESVENLAFAXINE
Original market date12-Aug-2024
Current status date12-Aug-2024
SourceHealth Canada DPD

Establishment licence of the holder

Angita Pharma Inc. — licence 101870, currently licensed, last inspection rating C (2025-01-13).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)

DINProductCompanyFormStrengthStatus
02525623AG-DESVENLAFAXINEANGITA PHARMA INC.Tablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGMarketed
02469847INTELLI-DESVENLAFAXINEINTELLIPHARMACEUTICS CORPTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGApproved
02469855INTELLI-DESVENLAFAXINEINTELLIPHARMACEUTICS CORPTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGApproved
02495147JAMP DESVENLAFAXINEJAMP PHARMA CORPORATIONTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGMarketed
02495139JAMP DESVENLAFAXINEJAMP PHARMA CORPORATIONTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGMarketed
02321092PRISTIQPFIZER CANADA ULCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGMarketed
02321106PRISTIQPFIZER CANADA ULCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGMarketed
02532166SPC-DESVENLAFAXINESUN PHARMA CANADA INCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGMarketed
02532158SPC-DESVENLAFAXINESUN PHARMA CANADA INCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGMarketed
02458217TEVA-DESVENLAFAXINETEVA CANADA LIMITEDTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGMarketed
02458225TEVA-DESVENLAFAXINETEVA CANADA LIMITEDTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGMarketed
02467119APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETSAPOTEX INCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGDormant
02467127APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETSAPOTEX INCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGDormant
02441667GD-DESVENLAFAXINEGENMED A DIVISION OF PFIZER CANADA ULCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGCancelled Pre Market
02441675GD-DESVENLAFAXINEGENMED A DIVISION OF PFIZER CANADA ULCTablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGCancelled Pre Market
02526913PRO-DESVENLAFAXINEPRO DOC LIMITEETablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 50 MGCancelled Post Market
02526921PRO-DESVENLAFAXINEPRO DOC LIMITEETablet (Extended-Release)DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) 100 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
277162022-03-04Abbreviated New Drug Submission (ANDS)Administrative: Licensing Agreement Between Two Companies
Request a quote for AG-DESVENLAFAXINE

How to read a Canadian DIN record